Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
| ▸ | PTPRZ1 | P23471 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15323249 | 0.84 | CA1 (0.31) | CA2CA1CA5ACA9 | |
| SCHEMBL17046690 | 0.81 | CA1 (0.33) | CA2CA1 | |
| SCHEMBL3300615 | 0.79 | L3MBTL1 (0.39) | ALDH1A1LMNA | |
| SCHEMBL1727931 | 0.76 | ELANE (0.38) | FAAHPRSS1PRSS2ELANEPRTN3 | |
| SCHEMBL3053466 | 0.76 | ALDH1A1 (0.36) | ALDH1A1CA2GPR3CA1CA5A | |
| SCHEMBL150811 | 0.75 | HTR6 (0.38) | CA2CA1CA5ACA9FAAH | |
| SCHEMBL7403541 | 0.74 | PTPN1 (0.41) | ALDH1A1CA2CA1CA9LMNA | |
| SCHEMBL8387010 | 0.73 | HTR6 (0.31) | CA2CA1CA5ACA9FAAH | |
| SCHEMBL3541896 | 0.72 | ALOX15 (0.39) | ALDH1A1CA2CA1CA9LMNA | |
| SCHEMBL600073 | 0.71 | ALDH1A1 (0.42) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117024430-A | Bipyrimidine fluorene compound, organic electroluminescent element and consumer product | 浙江八亿时空先进材料有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-114188606-B | Electrolyte and application thereof | 傲普(上海)新能源有限公司 | 2023-04-21 | — | — | CN | claimed |
| EP-4146643-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Bayer Aktiengesellschaft (DE) | 2023-03-15 | — | — | EP | claimed |
| CN-114907361-A | Trimeric heterocyclic derivative and application thereof | 北京八亿时空液晶科技股份有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-114583278-A | Low-temperature electrolyte of lithium ion battery and lithium ion battery | 傲普(上海)新能源有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114373989-A | Electrolyte and application thereof | 傲普(上海)新能源有限公司 | 2022-04-19 | — | — | CN | claimed |
| CN-114256431-A | Material for organic electroluminescent element, and consumer product | 上海八亿时空先进材料有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-114243112-A | Flame-retardant electrolyte and application thereof | 傲普(上海)新能源有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-114213409-A | Material for organic electroluminescent element, and consumer product | 上海八亿时空先进材料有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-114188606-A | Electrolyte and application thereof | 傲普(上海)新能源有限公司 | 2022-03-15 | — | — | CN | claimed |
| US-8309737-B2 | Phosphinate ruthenium complexes | IDENIX PHARMACEUTICALS, INC. (US) | 2012-11-13 | — | — | US | claimed |
| US-20120041191-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS, INC. (US) | 2012-02-16 | — | — | US | claimed |
| EP-2393822-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX Pharmaceuticals, Inc. (US) | 2011-12-14 | — | — | EP | claimed |
| WO-2010090976-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | WO | claimed |
| WO-2010065824-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2010-06-10 | — | — | WO | claimed |
| EP-1194417-A1 | PHENOXY FLUOROPYRIMIDINES | BAYER AG (DE) | 2002-04-10 | — | — | EP | claimed |
| US-6184234-B1 | EFFECTIVE AGRICULTURAL PESTICIDE FOR TOBACCO, BEETS, BEANS, CABBAGE CROPS | FMC CORPORATION | 2001-02-06 | — | — | US | claimed |
| WO-2000078733-A1 | PHENOXY FLUOROPYRIMIDINES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-12-28 | — | — | WO | claimed |
| EP-0550900-A1 | Herbicidal and plant-nematocidal compositions based on mercaptonicotinic acid derivatives | BAYER AG (DE) | 1993-07-14 | — | — | EP | claimed |
| US-4459304-A | MITICIDES, NEMATOCIDES, FUNGICIDES, BACTERICIDES, INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1984-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041191-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | RPIA, NDUFS7, PHOSPHO1 | ALDH1A1 3900/4885CA2 2631/4885GPR3 4519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.